Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Straccia, Marco ^a,b   Gresa Arribas, Núria ^a,b   Dentesano, Guido ^b   Ejarque Ortiz, Aroa ^b   Tusell, Josep M ^b   Serratosa, Joan ^b   Solà, Carme ^b   Saura, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CCAAT ENHANCER BINDING PROTEIN BETA; CD11B ANTIGEN; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDE; MICROTUBULE ASSOCIATED PROTEIN 2; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS2 PROTEIN, MOUSE;

ACTIN GENE; ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CCAAT ENHANCER BINDING PROTEIN BETA GENE; CELL DENSITY; CHROMATIN IMMUNOPRECIPITATION; COCULTURE; CONTROLLED STUDY; EMBRYO; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GRIESS REACTION; IMMUNE RESPONSE GENE; IMMUNOCYTOCHEMISTRY; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 4 GENE; INTERLEUKIN 6 GENE; MACROGLIA; MICROGLIA; MOUSE; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REGULATOR GENE; RNA 18S GENE; STAINING; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; WESTERN BLOTTING; ANIMAL; ASTROCYTE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; INFLAMMATION; METABOLISM; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; PREGNANCY;

ANIMALS; ASTROCYTES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; GENE EXPRESSION; INFLAMMATION; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PREGNANCY;

EID: 81055150384     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-156     Document Type: Article

References (60)

1. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 2009, 210:3-12. 10.1016/j.jneuroim.2009.02.003, 19269040.
2. Cho IH, Hong J, Suh EC, Kim JH, Lee H, Lee JE, Lee S, Kim CH, Kim DW, Jo EK, Lee KE, Karin M, Lee SJ. Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 2008, 131:3019-3033. 10.1093/brain/awn230, 2577806, 18819987.
3. Kaltschmidt B, Widera D, Kaltschmidt C. Signaling via NF-kappaB in the nervous system. Biochim Biophys Acta 2005, 1745:287-299. 10.1016/j.bbamcr.2005.05.009, 15993497.
4. Kwon D, Fuller AC, Palma JP, Choi IH, Kim BS. Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa B. Glia 2004, 45:287-296. 10.1002/glia.10331, 14730702.
5. Kim OS, Park EJ, Joe EH, Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem 2002, 277:40594-40601. 10.1074/jbc.M203885200, 12191995.
6. Wang X, Li C, Chen Y, Hao Y, Zhou W, Chen C, Yu Z. Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun 2008, 371:283-288. 10.1016/j.bbrc.2008.04.055, 18435916.
7. Zhang W, Petrovic JM, Callaghan D, Jones A, Cui H, Howlett C, Stanimirovic D. Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J Neuroimmunol 2006, 174:63-73. 10.1016/j.jneuroim.2006.01.014, 16504308.
8. Friedle SA, Brautigam VM, Nikodemova M, Wright ML, Watters JJ. The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia. Glia 2011, 59:1-13. 10.1002/glia.21071, 20878769.
9. Iadecola C, Salkowski CA, Zhang F, Aber T, Nagayama M, Vogel SN, Ross ME. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. J Exp Med 1999, 189:719-727. 10.1084/jem.189.4.719, 2192924, 9989987.
10. Drew PD, Xu J, Storer PD, Chavis JA, Racke MK. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem Int 2006, 49:183-189. 10.1016/j.neuint.2006.04.003, 16753239.
11. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. Nrf2, a multi-organ protector?. FASEB J 2005, 19:1061-1066. 10.1096/fj.04-2591hyp, 15985529.
12. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 2003, 23:3394-3406.
13. Ossipow V, Descombes P, Schibler U. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 1993, 90:8219-8223. 10.1073/pnas.90.17.8219, 47320, 8367486.
14. Welm AL, Timchenko NA, Darlington GJ. C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage. Mol Cell Biol 1999, 19:1695-1704. 83963, 10022857.
15. Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, Taub R. CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998, 102:996-1007. 10.1172/JCI3135, 508965, 9727068.
16. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365:561-575. 1222736, 12006103.
17. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 1998, 273:29279-29282. 10.1074/jbc.273.45.29279, 9792624.
18. Caivano M, Gorgoni B, Cohen P, Poli V. The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J Biol Chem 2001, 276:48693-48701. 10.1074/jbc.M108282200, 11668179.
19. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 1993, 90:9730-9734. 10.1073/pnas.90.20.9730, 47644, 7692452.
20. Reddy ST, Wadleigh DJ, Herschman HR. Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J Biol Chem 2000, 275:3107-3113. 10.1074/jbc.275.5.3107, 10652293.
21. Bradley MN, Zhou L, Smale ST. C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages. Mol Cell Biol 2003, 23:4841-4858. 10.1128/MCB.23.14.4841-4858.2003, 162211, 12832471.
22. Cardinaux JR, Allaman I, Magistretti PJ. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 2000, 29:91-97. 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I, 10594926.
23. Cardinaux JR, Magistretti PJ. Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism. J Neurosci 1996, 16:919-929.
24. Ejarque-Ortiz A, Medina MG, Tusell JM, Perez-Gonzalez AP, Serratosa J, Saura J. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 2007, 55:178-188. 10.1002/glia.20446, 17078024.
25. Perez-Capote K, Saura J, Serratosa J, Sola C. Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli. Neurosci Lett 2006, 410:25-30. 10.1016/j.neulet.2006.09.078, 17070994.
26. Kapadia R, Tureyen K, Bowen KK, Kalluri H, Johnson PF, Vemuganti R. Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J Neurochem 2006, 98:1718-1731. 10.1111/j.1471-4159.2006.04056.x, 16899075.
27. Cortes-Canteli M, Luna-Medina R, Sanz-Sancristobal M, Alvarez-Barrientos A, Santos A, Perez-Castillo A. CCAAT/enhancer binding protein beta deficiency provides cerebral protection following excitotoxic injury. J Cell Sci 2008, 121:1224-1234. 10.1242/jcs.025031, 18388310.
28. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Constantini F, Poli V. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 1995, 14:1932-1941. 398292, 7744000.
29. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986, 6:2163-2178.
30. Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189. 10.1002/glia.10274, 14603460.
31. Gresa-Arribas N, Serratosa J, Saura J, Sola C. Inhibition of CCAAT/enhancer binding protein delta expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J Neurochem 2010, 115:526-536. 10.1111/j.1471-4159.2010.06952.x, 20722966.
32. Saura J, Petegnief V, Wu X, Liang Y, Paul SM. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J Neurochem 2003, 85:1455-1467. 10.1046/j.1471-4159.2003.01788.x, 12787065.
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
34. Buira SP, Dentesano G, Albasanz JL, Moreno J, Martin M, Ferrer I, Barrachina M. DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain. J Neurochem 2010, 115:283-295. 10.1111/j.1471-4159.2010.06928.x, 20666933.
35. Liu YW, Tseng HP, Chen LC, Chen BK, Chang WC. Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein beta and delta in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages. J Immunol 2003, 171:821-828.
36. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934. 10.1016/j.cell.2010.02.016, 2873093, 20303880.
37. Sola C, Casal C, Tusell JM, Serratosa J. Astrocytes enhance lipopolysaccharide-induced nitric oxide production by microglial cells. Eur J Neurosci 2002, 16:1275-1283. 10.1046/j.1460-9568.2002.02199.x, 12405988.
38. Saura J, Angulo E, Ejarque A, Casado V, Tusell JM, Moratalla R, Chen JF, Schwarzschild MA, Lluis C, Franco R, Serratosa J. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem 2005, 95:919-929. 10.1111/j.1471-4159.2005.03395.x, 16092928.
39. Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 2007, 4:26. 10.1186/1742-2094-4-26, 2140055, 17937799.
40. Sterneck E, Tessarollo L, Johnson PF. An essential role for C/EBPbeta in female reproduction. Genes Dev 1997, 11:2153-2162. 10.1101/gad.11.17.2153, 275394, 9303532.
41. Schroder K, Sweet MJ, Hume DA. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 2006, 211:511-524. 10.1016/j.imbio.2006.05.007, 16920490.
42. Meir O, Dvash E, Werman A, Rubinstein M. C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models. PLoS One 2010, 5:e9516. 10.1371/journal.pone.0009516, 2831074, 20209087.
43. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr Opin Cell Biol 2008, 20:180-185. 10.1016/j.ceb.2008.02.002, 18358708.
44. Xia C, Cheshire JK, Patel H, Woo P. Cross-talk between transcription factors NF-kappa B and C/EBP in the transcriptional regulation of genes. Int J Biochem Cell Biol 1997, 29:1525-1539. 10.1016/S1357-2725(97)00083-6, 9570146.
45. Ejarque-Ortiz A, Gresa-Arribas N, Straccia M, Mancera P, Sola C, Tusell JM, Serratosa J, Saura J. CCAAT/enhancer binding protein delta in microglial activation. J Neurosci Res 2010, 88:1113-1123.
46. Ramberg V, Tracy LM, Samuelsson M, Nilsson LN, Iverfeldt K. The CCAAT/enhancer binding protein (C/EBP) delta is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-beta peptide. J Neuroinflammation 2011, 8:34. 10.1186/1742-2094-8-34, 3096570, 21492414.
47. Gorgoni B, Maritano D, Marthyn P, Righi M, Poli V. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J Immunol 2002, 168:4055-4062.
48. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993, 151:2132-2141.
49. Chen J, Ivashkiv LB. IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc Natl Acad Sci USA 2010, 107:19438-19443. 10.1073/pnas.1007816107, 2984206, 20974955.
50. Schwartz C, Beck K, Mink S, Schmolke M, Budde B, Wenning D, Klempnauer KH. Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity. EMBO J 2003, 22:882-892. 10.1093/emboj/cdg076, 145436, 12574124.
51. Li H, Gade P, Nallar SC, Raha A, Roy SK, Karra S, Reddy JK, Reddy SP, Kalvakolanu DV. The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma. J Biol Chem 2008, 283:13077-13086. 10.1074/jbc.M800604200, 2442347, 18339625.
52. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394. 10.1038/nn1997, 17965659.
53. Katsuki H, Okawara M, Shibata H, Kume T, Akaike A. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture. J Neurochem 2006, 97:1232-1242. 10.1111/j.1471-4159.2006.03752.x, 16638023.
54. Xie Z, Wei M, Morgan TE, Fabrizio P, Han D, Finch CE, Longo VD. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J Neurosci 2002, 22:3484-3492.
55. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999, 5:1403-1409. 10.1038/70978, 10581083.
56. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 2007, 27:3328-3337. 10.1523/JNEUROSCI.5321-06.2007, 17376993.
57. Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 2005, 58:963-967. 10.1002/ana.20682, 16240369.
58. Gao X, Chen H, Schwarzschild MA, Ascherio A. Use of ibuprofen and risk of Parkinson disease. Neurology 2011, 76:863-869. 10.1212/WNL.0b013e31820f2d79, 21368281.
59. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001, 22:407-412. 10.1016/S0197-4580(00)00241-4, 11378246.
60. Sterneck E, Johnson PF. CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J Neurochem 1998, 70:2424-2433.